FDA Inspection 1223760 — Fougera Pharmaceuticals, LLC.

Fougera Pharmaceuticals, LLC. — FEI 2410271

The FDA completed an inspection of Fougera Pharmaceuticals, LLC. on November 17, 2023 in Hicksville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 17, 2023
Fiscal Year
2024
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Hicksville, NY (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures